Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Ryan J Selhorn is Chief Financial Officer at Aytu Biopharma. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jul 30, 2026, each linked to the official Form 4.
Chief Financial Officer
Disclosures on record
1
Companies involved
1
As of the latest filing on , Ryan J Selhorn reported holding 74,743 shares of Aytu Biopharma (AYTU), worth about $199K at the last close of $3 (Nov 17, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Aytu Biopharma AYTU | 74,743 | 75K direct | $3 | $199K | Jul 28, 2026 |
Is this Ryan J Selhorn’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Aytu BiopharmaAYTU
Jul 28, 202625Kdisclosed Jul 30
DetailsOfficial recordOn the latest SEC Form 4, dated Jul 28, 2026, Ryan J Selhorn reported holding 74,743 shares of Aytu Biopharma (AYTU). At the last close of $3 on Nov 17, 2026, that is about $199K. This is the stake disclosed in filings, not a net worth.